HealthBeacon (DUB:HBCN) Change In Receivables : €-0.95 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is HealthBeacon Change In Receivables?

HealthBeacon's change in receivables for the quarter that ended in Dec. 2022 was €-1.18 Mil. It means HealthBeacon's Accounts Receivable increased by €1.18 Mil from Jun. 2022 to Dec. 2022 .

HealthBeacon's change in receivables for the fiscal year that ended in Dec. 2022 was €-0.95 Mil. It means HealthBeacon's Accounts Receivable increased by €0.95 Mil from Dec. 2021 to Dec. 2022 .

HealthBeacon's Accounts Receivable for the quarter that ended in Dec. 2022 was €1.35 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. HealthBeacon's Days Sales Outstanding for the six months ended in Dec. 2022 was 178.15.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. HealthBeacon's liquidation value for the six months ended in Dec. 2022 was €6.82 Mil.

HealthBeacon Change In Receivables Historical Data

The historical data trend for HealthBeacon's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthBeacon Change In Receivables Chart

HealthBeacon Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-0.39

0.09

0.13

-1.93

-0.95

HealthBeacon Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Change In Receivables	Get a 7-Day Free Trial			0.20	-0.34	-1.58	0.22	-1.18

HealthBeacon Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.95 Mil.

HealthBeacon (DUB:HBCN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

HealthBeacon's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.35	/	1.383	*	91
=	178.15

2. In Ben Graham's calculation of liquidation value, HealthBeacon's accounts receivable are only considered to be worth 75% of book value:

HealthBeacon's liquidation value for the quarter that ended in Dec. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12.168	-	7.343	+	0.75 * 1.35	+	0.5 * 1.969
=	6.82

HealthBeacon Change In Receivables Related Terms

Thank you for viewing the detailed overview of HealthBeacon's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthBeacon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthBeacon PLC (DUB:HBCN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Naas Road, Muirfield Drive, Unit 20, Naas Road Business Park, Dublin, IRL, D12WD85

Website

https://www.healthbeacon.com

HealthBeacon PLC is a digital therapeutics company that develops products for managing injectable medications for patients in the home. Its Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence-driven data analytics. It has three operating segments: Direct-to-Consumer, Patient safety Hub and Patient Support Programmes. The company generates the majority of revenue from the DTC segment.

HealthBeacon Headlines

No Headlines